Cargando…
CIB1 is an endogenous inhibitor of agonist-induced integrin αIIbβ3 activation
In response to agonist stimulation, the αIIbβ3 integrin on platelets is converted to an active conformation that binds fibrinogen and mediates platelet aggregation. This process contributes to both normal hemostasis and thrombosis. Activation of αIIbβ3 is believed to occur in part via engagement of...
Autores principales: | Yuan, Weiping, Leisner, Tina M., McFadden, Andrew W., Wang, Zhengyan, Larson, Mark K., Clark, Shantres, Boudignon-Proudhon, Christel, Lam, Stephen C.-T., Parise, Leslie V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063547/ https://www.ncbi.nlm.nih.gov/pubmed/16418530 http://dx.doi.org/10.1083/jcb.200505131 |
Ejemplares similares
-
Essential role of CIB1 in regulating PAK1 activation and cell migration
por: Leisner, Tina M., et al.
Publicado: (2005) -
CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling
por: Leisner, Tina M., et al.
Publicado: (2012) -
CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019) -
Tumor growth and angiogenesis is impaired in CIB1 knockout mice
por: Zayed, Mohamed A, et al.
Publicado: (2010) -
CIB1 is a Regulator of Pathological Cardiac Hypertrophy
por: Heineke, Joerg, et al.
Publicado: (2010)